The new HIV PrEP option could drastically reduce the number of new cases by offering a new alternative to daily pills or every-other-month injections.

The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that ...

And when I say suffer, I actually do suffer.” Nehal’s journey through menopause reflects the common struggles many women ...

The at-home test is billed as a non-invasive alternative to hormonal birth control methods — and early tests have shown ...

The FDA has approved a new, twice-yearly PrEP injection from pharmaceutical giant Gilead. The drug is lenacapavir. The ...

The test, which uses saliva to track a hormone that plays a role in fertility, is expected to roll out across Europe this ...

The abortion pill reversal drug has saved the lives of more than 7,000 unborn children since 2007, according to estimates ...

The clearance ushers in a closely-watched launch for Gilead, which aims to show a long-acting injection can upend a market ...

With the FDA’s much-anticipated nod for Gilead Sciences’ long-acting HIV pre-exposure prophylaxis (PrEP) injection Yeztugo ...

After months of waking up with headaches, Claire visited her GP. Her life was turned upside down as doctors discovered what ...

Jordan Poyer's wife, Rachel Bush, shared something personal on Instagram on Saturday. She reposted a message from a nurse named S. Clovinson.